I N N O V A T I O N I N G L U C O S E M E A S U R E M E N T T E C H N O L O G Y SM
Public Pages: January 31, 2021
Investment: January 1, 2021
Shareholders: May 17, 2021
TecMed, Inc. © 2021 All Rights Reserved
Today we are a small, but deeply invested company that offers intellectual property solutions to glucose measurement problems that have plagued the medical care community for decades. TecMed's proven and patented optical measurement technology meets and exceeds both the industry standard and the requirements of recent healthcare mandates, setting the stage for immediate and long-term opportunities in the modern health care environment. Our IP portfolio of technology is unique in the medical device industry. It is un-paralleled in its accuracy and reliability for glucose measurement.